Routine

Pityriasis rosea

pityriasis rosea, herald patch, Christmas tree distribution, HHV-6, HHV-7 · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Common self-limiting papulosquamous eruption, probably linked to HHV-6/7 reactivation, typically in adolescents and young adults. A single 'herald patch' is followed over days-weeks by a symmetrical truncal eruption of oval scaly macules along skin cleavage lines ('Christmas-tree' pattern). Resolves spontaneously over 6-12 weeks. Key is to exclude secondary syphilis and drug eruptions.

Red flags

  • Palmoplantar lesions, mucous patches, generalised lymphadenopathy, or sexual risk - exclude secondary syphilis
  • Atypical distribution/morphology or failure to resolve by 3 months - reconsider diagnosis/biopsy
  • New medication preceding eruption - pityriasis rosea-like drug eruption (may not self-resolve)
  • Widespread pityriasis rosea in early pregnancy (counsel/monitor)

Assessment

Differential diagnosis

  • Secondary syphilis (palms/soles, lymphadenopathy, mucous patches - MUST exclude)
  • Guttate psoriasis
  • Tinea corporis (herald patch mimic - KOH)
  • Nummular eczema
  • Pityriasiform drug eruption (ACEi, NSAIDs, antimalarials, some biologics)
  • Viral exanthem
  • Pityriasis lichenoides

Investigations

  • Clinical diagnosis (herald patch + collarette scale + cleavage-line distribution)
  • Syphilis serology (RPR/VDRL + treponemal) if any atypia, palmoplantar involvement, mucosal lesions, lymphadenopathy, or sexual risk
  • KOH of herald patch if tinea suspected
  • Medication review for pityriasis rosea-like drug eruption
  • No routine bloods otherwise

Management

  • Confirm clinical diagnosis and reassure - self-limiting, not contagious, resolves in 6-12 weeks
  • Exclude secondary syphilis (serology) when any atypical feature, palm/sole lesions or sexual risk
  • Symptomatic relief: emollient; mild-moderate topical corticosteroid and/or oral antihistamine for itch
  • Advise that post-inflammatory pigment change may persist (esp. darker skin) but fades
  • Severe/extensive/very itchy or persistent: consider NB-UVB phototherapy; some evidence for oral aciclovir early in course to speed resolution [verify local]
  • In pregnancy: usually benign but counsel re small reported risk in early widespread disease - involve obstetrics if concerned

Drugs & doses

Emollient liberally for scale and comfort
Mild-moderate topical corticosteroid (e.g. hydrocortisone 1% or clobetasone butyrate 0.05%) once-twice daily for itch
Oral antihistamine (e.g. cetirizine 10 mg ORAL once daily, or sedating chlorphenamine at night) for pruritus
Aciclovir 800 mg ORAL five times daily for 7 days early (within first week) may hasten resolution in severe cases [verify local dose]
NB-UVB phototherapy for severe/persistent itch [verify local]

Disposition

Discharge with reassurance and symptomatic advice. GP follow-up if not resolving by 3 months or atypical. Syphilis screening where indicated; dermatology referral only for diagnostic doubt or severe/persistent disease.

Complications & pitfalls

  • Post-inflammatory hyper/hypopigmentation (usually temporary)
  • Persistent pruritus
  • Rare prolonged or recurrent course
  • Reported association with adverse pregnancy outcome if widespread in first 15 weeks (uncertain)

Exam pearls

  • Herald patch + collarette of fine scale + 'Christmas-tree' truncal pattern along Langer's lines is diagnostic
  • Always consider secondary syphilis - 'the great imitator' - if palms/soles involved or any risk; check serology
  • Self-limiting: reassurance and symptomatic treatment are usually all that is needed
  • A pityriasis rosea-like drug eruption will not self-resolve - review the drug chart
  • Early oral aciclovir has limited evidence for shortening severe cases

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.